麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 17 2025

Full Issue

Viewpoints: FDA Takes a Back Seat On Oversight Of Biologics Under RFK Jr.; Universal Ban On PFAS Is Overdue

Editorial writers delve into these public health issues.

Health and Human Services Secretary Robert F. Kennedy Jr. seems ready to flip the script on Food and Drug Administration oversight of biologics like stem cells. Normally, the FDA is in the driver鈥檚 seat, determining proper oversight and regulations based on its scientific, medical, and legal expertise. However, under Kennedy, the FDA instead looks ready to follow the lead of a hodge-podge of state laws, politicians, and stem cell clinic doctors. (Paul Knoepfler, 7/17)

The more you learn about PFAS 鈥 per- and polyfluoroalkyl substances 鈥 the worse it gets. Though improvements in monitoring and remediation techniques are welcome, what the world needs first and foremost is a universal ban on the chemicals. In fact, we needed it yesterday. (Lara Williams, 7/17)

In March 2020, I disobeyed an order from the City of San Francisco to close down the H.I.V. clinic where I serve as medical director. I knew that complying with the order, which came as part of the city鈥檚 stringent Covid-19 lockdown, would have left our poor and homeless patients without anywhere to get treatment. (Monica Gandhi, 7/17)

For decades, the consensus among research ethicists and federal regulators has been that compensation of medical research participants runs a serious risk of undue influence or inducement: making a participant an offer that is so enticing that they can鈥檛 refuse, even against their better judgment. In practice, this means that institutional review boards (IRBs) often try to avoid payment that is 鈥渢oo high.鈥 But what if this approach is wrong? (Jake Eberts and Jill Fisher, 7/17)

Some days, I feel that my body and the American body politic are both dying of a similar disease: a deadly cancer, impervious to standard treatment, that is rapidly spreading through blood, bone and lymph to destroy vital organs and connective tissue. (Kim Fellner, 7/15)

As we approach the start of fraternity hazing season, a new Missouri law will go a long way to help prevent future tragedies. On July 10, Gov. Mike Kehoe signed what is now known as Danny鈥檚 Law. State Rep. Sherri Gallick and state Sen. Kurtis Gregory co-sponsored the bill, which is intended to incentivize witnesses to hazing incidents to call 911 before the damage is irreversible. (David W. Bianchi, 7/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优